Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ropeginterferon alfa-2b Injection

Approval Number

国药准字SC20240001

Company

药华医药股份有限公司

Registration Date

June 28, 2024

Drug Information

Generic Name

罗培干扰素α-2 b 注射液

Trade Name

百斯锐明

Dosage Form

注射剂

Strength

预填充式注射器装：500 μg（1 ml）/支

Drug Type

生物制品

Registration Date

June 28, 2024

Expiry Date

June 27, 2029

Company Information

Applicant Company

Company Name

药华医药股份有限公司

Company Address

中国台湾台北市南港区园区街3号13楼

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy